Midsona

Midsona invites investors, analysts and the media to a presentation of the interim report for Q1 2023, where CEO Peter Åsberg and CFO Max Bokander comment on the report. The presentation will be held at 11.00 CEST and can be followed via telephone conference or audio broadcast. The report will be released at 8.00 CEST and will be available at. https://www.midsona.com/en/investors/reports/

The presentation is in English and is followed by a question-and-answer session. Questions can be asked orally via the conference call.

The webcast can be accessed via this link: https://ir.financialhearings.com/midsona-q1-2023

To attend the presentation via teleconference and to ask questions, please klick on the link. After your registration you will receive a dial-in number and a conference ID: https://conference.financialhearings.com/teleconference/?id=200673

After the presentation, a recorded version will be available on:

https://www.midsona.com/investerare/finansiell_information/

27 April 2023              Interim report January-March 2023

4 May 2023                 Annual general meeting

20 July 2023               Half year financial report January-June 2023

26 October 2023         Interim report January-September 2023

The financial calendar is also published on:

http://www.midsona.com/en/investors/calendar/

For more information, please contact:

Peter Åsberg, CEO and president

Telephone: +46 730 26 16 32

E-mail: peter.asberg@midsona.com

Max Bokander, CFO

Telephone: +46 708 65 13 64

E-mail: max.bokander@midsona.com

about midsona

Midsona develops and markets strong brands within health and well-being, with products that help people live a healthier and more sustainable life, with an increased understanding of the origin of the raw material and with transparency as to the content. The Midsona share is listed on NASDAQ OMX Stockholm, Mid Cap. For more information www.midsona.com/en